added 2007 Thu Feb 22 0:18:13 by bhartzer
An international study published in today's New England Journal of Medicine showed that patients with Chronic Obstructive Pulmonary Disease (COPD) who took Advair Diskus(R) 500/50 (fluticasone propionate and salmeterol inhalation powder) reduced their risk of death by 17.5 percent over three years compared to patients on placebo
An international study published in today's New England Journal of Medicine showed that patients with Chronic Obstructive Pulmonary Disease (COPD) who took Advair Diskus(R) 500/50 (fluticasone propionate and salmeterol inhalation powder) reduced their risk of death by 17.5 percent over three years compared to patients on placebo
